San Francisco, 22 August 2025: The Report Duodenoscopes Market Size, Share & Trends Analysis Report By Product (Reusable, Disposable), By Application (Diagnostics, Therapeutics/Treatment), By End Use, By Region, And Segment Forecasts, 2025 - 2030

The global duodenoscopes market is anticipated to reach USD 2.20 billion by 2030 and is anticipated to expand at a CAGR of 5.53% from 2024 to 2030, according to a new report by Grand View Research, Inc. Advances in technology have resulted in duodenoscopes that offer better imaging capabilities, enhanced maneuverability, and integration with cutting-edge diagnostic tools, which increases their effectiveness in both diagnostic and therapeutic applications. Moreover, the rising prevalence of gastrointestinal disorders has escalated the demand for endoscopic procedures, driving market growth further. A growing focus on patient safety and infection control has led to a rise in single-use duodenoscopes, which help reduce the risk of cross-contamination.

The shift towards minimally invasive procedures refers to a broader trend in modern medicine where doctors prefer using techniques involving smaller incisions, less tissue damage, and quicker patient recovery times. Instead of traditional open surgeries, which are more invasive and require more extended hospital stays, minimally invasive methods allow for faster healing, fewer complications, and less pain.

The market is growing due to technological advancements that enhance the effectiveness and user-friendliness of these devices. Duodenoscopes, used mainly for ERCP procedures, feature high-definition imaging, improved flexibility, and control, allowing for better detection of abnormalities and safer procedures. Some models now include AI features for real-time image analysis and navigation, leading to quicker and more accurate diagnoses. These innovations are prompting hospitals and clinics to invest in newer models, driving market growth.

Endoscopic procedures, such as Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP), are valuable in detecting & assessing cancer in the gastrointestinal tract, lung, and other areas. These procedures allow for precise visualization of internal tissues, biopsy collection, and even the removal of precancerous growths or early-stage tumors without open surgery. This improves patient outcomes and significantly reduces recovery times & the risk of complications associated with invasive surgical procedures.

Moreover, advancements in endoscopic technologies, including high-definition visualization and the integration of artificial intelligence (AI) for enhanced diagnosis, are making these procedures even more effective at detecting and treating cancer at its early stages.

Request sample report of Duodenoscopes Market@ https://www.grandviewresearch.com/industry-analysis/duodenoscopes-market-report/request/rs1

The market growth is driven by increasing incidences of gastrointestinal disorders, technological advancements in endoscopic devices, rising acceptance of ERCP procedures, significant investments in research and development, and supportive regulatory frameworks. These factors contribute to market growth over the forecast period.

The key driver for market growth is the rising prevalence of gastrointestinal disorders, particularly cancers related to the pancreas and bile ducts. The increasing number of diagnoses related to pancreatic cancer, bile duct cancer, and other gastrointestinal diseases necessitate advanced diagnostic tools such as duodenoscopes. For instance, per the Anesthesia Patient Safety Foundation report published in October 2022, over 500,000 endoscopic retrograde cholangiopancreatography (ERCP) procedures are performed annually in the U.S.

Technological innovations play a crucial role in enhancing the capabilities and efficiency of duodenoscopes. For instance, in April 2024, Ambu A/S received U.S. FDA clearance for its new generation duodenoscopy tools, such as Ambu aBox 2 and Ambu aScope Duodeno 2, for use in ERCP procedures.

In addition, continuous advancements in imaging technology improve diagnostic accuracy and procedural outcomes. The introduction of flexible video duodenoscopes has significantly enhanced visualization during procedures, making them more effective than traditional non-video models. Furthermore, developments such as single-use duodenoscopes are emerging to address infection control issues associated with reusable devices.

The growing acceptance and demand for ERCP procedures contribute to market expansion. As healthcare providers increasingly recognize the benefits of minimally invasive techniques for diagnosing and treating conditions affecting the biliary tree and pancreas, the utilization rates for duodenoscopes are expected to rise. This trend is further supported by increased patients' awareness of available treatment options.

Research and development (R&D) investments drive innovation within the market. Companies focus on developing new technologies that enhance device safety and effectiveness while minimizing infection risks. The advancements in duodenoscope technology, particularly in imaging and safety, have led to the launch of new models. For instance, in June 2020, Olympus launched the TJF-Q190V duodenoscope, which received FDA clearance in January 2020 due to its innovative design that includes a sterile, disposable distal endcap to improve reprocessing and reduce contamination risks. This new model aims to facilitate safer ERCP procedures by providing physicians with advanced tools while adhering to stringent patient safety standards.